Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Efficacy of Wharton Jelly in Erectile Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the efficacy of Wharton Jelly for erectile dysfunction associated with type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wharton jelly

Snippet

Sponsor: Sophia Al-Adwan | Conditions: Erectile Dysfunction Associated With Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED